Pediatric-Onset Multiple Sclerosis: A Single Center Study

被引:15
|
作者
Yamamoto, Erin [1 ]
Ginsberg, Matthew [2 ]
Rensel, Mary [3 ]
Moodley, Manikum [4 ]
机构
[1] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA
[2] Childrens Hosp Pittsburgh, Dept Pediat Neurol, Pittsburgh, PA 15213 USA
[3] Cleveland Clin, Dept Neurol, Mellen Ctr, Cleveland, OH 44106 USA
[4] Cleveland Clin, Neurol Inst, Ctr Pediat Neurol, 9500 Euclid Ave,S60, Cleveland, OH 44195 USA
关键词
pediatric-onset multiple sclerosis; clinical features; investigations; treatment; outcome; VITAMIN-D STATUS; BODY-MASS INDEX; RELAPSE RATE; RISK; CHILDHOOD; OBESITY; CHILDREN; DISEASE; MS; DEFINITIONS;
D O I
10.1177/0883073817739789
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Pediatric-onset multiple sclerosis (POMS), once thought to be rare, is now being diagnosed in increasing numbers in children. Despite improvements to diagnostic criteria, the diagnosis and management of POMS remains challenging. The aim of this study is to retrospectively describe a growing POMS patient population seen at a single center over a 13 year period. Epidemiologic, clinical, neuroimaging, laboratory features and therapeutic management and outcome data were collected and analyzed. These data support associations between MS and environmental triggers such as obesity and vitamin D deficiency. Presenting symptoms, magnetic resonance imaging and laboratory findings were consistent with the existing literature; however, the prevalence of cortical lesions and abnormal saccadic pursuit is higher than other reports. Data also demonstrate a shift in practice from first- to second-line therapies over the observed period.
引用
收藏
页码:98 / 105
页数:8
相关论文
共 50 条
  • [1] Update on pediatric-onset multiple sclerosis
    Ruet, A.
    REVUE NEUROLOGIQUE, 2018, 174 (06) : 398 - 407
  • [2] Fingolimod in pediatric-onset multiple sclerosis
    Mauro Zaffaroni
    Neurological Sciences, 2021, 42 : 1 - 4
  • [3] Fingolimod in pediatric-onset multiple sclerosis
    Zaffaroni, Mauro
    NEUROLOGICAL SCIENCES, 2021, 42 (SUPPL 1) : 1 - 4
  • [4] Obesity in Pediatric-Onset Multiple Sclerosis A French Cohort Study
    Milles, Pauline
    De Filippo, Gianpaolo
    Maurey, Helene
    Tully, Thomas
    Deiva, Kumaran
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2021, 8 (05):
  • [5] The Use of Natalizumab in Pediatric-Onset Multiple Sclerosis
    Ahmed, Samar
    Al-Hashel, Jasem
    Behbehani, Raed
    Alroughani, Raed
    NEUROLOGY, 2016, 86
  • [6] The use of natalizumab in pediatric-onset multiple sclerosis
    Alroughani, Raed
    Akhtar, Saeed
    Ahmed, Samar
    Al-Hashel, Jasem
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP7 - NP8
  • [7] Rituximab treatment in pediatric-onset multiple sclerosis
    Breu, Markus
    Sandesjo, Fredrik
    Milos, Ruxandra-Iulia
    Svoboda, Jan
    Salzer, Jonatan
    Schneider, Lisa
    Reichelt, Julian Benedikt
    Bertolini, Annikki
    Blaschek, Astrid
    Fink, Katharina
    Hoeftberger, Romana
    Lycke, Jan
    Rostasy, Kevin
    Seidl, Rainer
    Siegert, Sandy
    Wickstrom, Ronny
    Kornek, Barbara
    EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (05)
  • [8] Validation of the Swedish Multiple Sclerosis registry for pediatric-onset multiple sclerosis
    Sandesjo, Fredrik
    Alping, Peter
    Fink, Katharina
    Wickstrom, Ronny
    Piehl, Fredrik
    Frisell, Thomas
    Mckay, Kyla A.
    MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2025, 11 (01)
  • [9] Pediatric Onset Multiple Sclerosis: A Single Center Experience
    Yamamoto, E.
    Ginsberg, M.
    Rensel, M.
    Moodley, M.
    ANNALS OF NEUROLOGY, 2016, 80 : S332 - S332
  • [10] Rates of Depression and Suicidality in Pediatric-Onset Multiple Sclerosis: A Pilot Study
    Sobejano, Isabella
    Stoney, Sarah
    Kunzelman, Elizabeth
    Black, Chelsea
    Waldman, Amy
    Hopkins, Sarah
    Narula, Sona
    Banwell, Brenda
    NEUROLOGY, 2023, 100 (17)